Mereo BioPharma Group plc

NasdaqCM:MREO Stock Report

Market Cap: US$435.5m

Mereo BioPharma Group Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqCM:MREO Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
17 Nov 23BuyUS$984,120Rubric Capital Management LPCompany475,666US$2.08
13 Nov 23BuyUS$2,966Rubric Capital Management LPCompany1,440US$2.06
10 Nov 23BuyUS$720,643Rubric Capital Management LPCompany351,639US$2.06
07 Nov 23BuyUS$899,742Rubric Capital Management LPCompany437,724US$2.06
01 Nov 23BuyUS$284,678Rubric Capital Management LPCompany144,426US$1.98
30 Oct 23BuyUS$775,787Rubric Capital Management LPCompany433,695US$1.81
15 Jun 23BuyUS$1,794,625Rubric Capital Management LPCompany1,250,000US$1.45

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of MREO?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders5,057,6583.61%
Institutions29,223,99620.9%
General Public33,880,59424.2%
Hedge Funds71,861,84951.3%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 12.3%.


Top Shareholders

Top 25 shareholders own 73.82% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
14.2%
Rubric Capital Management LP
19,942,997US$62.0m0%1.78%
11.4%
Rock Springs Capital Management LP
15,967,702US$49.7m0%1.24%
7.18%
Adage Capital Management, L.P.
10,050,000US$31.3m279%0.05%
6.98%
Soleus Capital Management, L.P.
9,777,419US$30.4m1.03%2.92%
6.25%
Mangrove Partners IM, LLC
8,752,893US$27.2m58.2%2.21%
5.26%
Suvretta Capital Management, LLC
7,370,838US$22.9m0.09%0.87%
4.43%
683 Capital Management, LLC
6,200,000US$19.3m3.33%1.54%
3.03%
Alkeon Capital Management, LLC
4,238,100US$13.2m13.4%0.09%
2.65%
Tejara Capital Limited., Asset Management Arm
3,713,129US$11.5m15.5%3.94%
2.38%
Clearline Capital LP
3,326,718US$10.3m7.22%0.99%
1.86%
Denise Scots-Knight
2,609,154US$8.1m1,110%no data
1.45%
Goldman Sachs Group, Investment Banking and Securities Investments
2,023,672US$6.3m0%no data
1.28%
Renaissance Technologies LLC
1,798,009US$5.6m4.08%0.01%
1.11%
abrdn plc
1,551,082US$4.8m0%no data
1.01%
Millennium Management LLC
1,410,317US$4.4m13.4%no data
0.59%
Charles Sermon
825,287US$2.6m502%no data
0.56%
Dafna Capital Management, LLC
778,813US$2.4m-19.1%0.51%
0.48%
Monaco Asset Management S.A.M.
676,494US$2.1m13.6%0.66%
0.28%
Christine Fox
389,061US$1.2m0%no data
0.25%
Nationwide Fund Advisors
351,905US$1.1m0%0.01%
0.24%
Formidable Asset Management, LLC
331,914US$1.0m0%0.21%
0.23%
Citadel Advisors LLC
324,819US$1.0m-85.5%no data
0.23%
Tidal Investments LLC
319,390US$993.3k-3.77%0.02%
0.23%
Tareno International Asset Managers
318,089US$989.3k0%0.37%
0.22%
Two Sigma Investments, LP
311,060US$967.4k118%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.